Newsroom

Selected Publications

Value in Health

Value in Health. 2021;
24(2): pp. 244-249

“Health Technology Assessment with Diminishing Returns to Health: The Generalized Risk-Adjusted Cost Effectiveness (GRACE) Approach.”

Lakdawalla, Darius N. and Charles Phelps

A novel and mathematically rigorous framework for calculating cost-effectiveness when outcomes are uncertain and patients care about risk.

Read More >

Value in Health

European Journal of Health Economics. 2021

“A Guide to Extending and Implementing Generalized Risk-Adjusted Cost-Effectiveness (GRACE).”

Lakdawalla, Darius N. and Charles Phelps

A presentation of generalized risk-adjusted cost-effectiveness (GRACE), an improvement upon traditional cost-effectiveness useful for predicting value of medical technology with uncertain outcomes.]

Read More >

Value in Health

Statistics in Medicine. 2021;
40(25):5487-5500

“Penalized regression for left-truncated and right-censored survival data.”

McGough, Sarah F., Devin Incerti, Svetlana Lyalina, Ryan Copping, Balasubramanian Narasimhan, Robert Tibshirani

Evaluates statistical methods for prediction and validation of survival models with high-dimensional real-world clinicogenomic data.

Read More >

Value in Health

hesim: arXiv preprint arXiv:2012.09437 (2021)

“Health Economic Simulation Modeling and Decision Analysis.”

Incerti, Devin, and Jeroen P. Jansen

Describes an open source software package, hesim, developed by the authors for simulating the value of medical technologies.

Read More >

Value in Health

Health Economics. Published online October 7, 2020

“Predicting quantity and quality of life with the Future Elderly Model”

Ermini Leaf, Duncan, Bryan Tysinger, Dana P. Goldman, and Darius N. Lakdawalla

Validation of a pathbreaking microsimulation model that predicts health outcomes for a representative sample of Americans.

Read More >

Value in Health

Value in Health, 2017; 20(7): pp. 866-875

“Predicting Real-World Effectiveness of Cancer Therapies Using Overall Survival and Progression-Free Survival from Clinical Trials: Empirical Evidence for the ASCO Value Framework.”

Lakdawalla, Darius N., Jason Shafrin, Ningqi Hou, Desi Peneva, Seanna Vine, Jinhee Park, Jie Zhang, Ron Brookmeyer and Robert Figlin

A novel statistical approach to estimating real-world effectiveness outcomes from clinical trial efficacy data.

Read More >

Op-Eds

Fortune

Fortune. 2017

“Innovative Drugs Deserve Innovative Pricing”

Agus, D. and D.P. Goldman

Read More >

Harvard Business Review

Harvard Business Review. 2015

“Understanding Health Care’s Short-Termism Problem”

Chandra, A. and D.P. Goldman

Read More >

HealthAffairs

Health Affairs Blog. 2012

When Epidemiology Goes Astray: Valuing Cancer Care In The United States And Europe

Eber, M., D.P. GoldmanD.N., Lakdawalla, and T. Philipson

Read More >

HealthAffairs

Health Affairs Blog. 2015

Moving Beyond Price-Per-Dose In The Pharmaceutical Industry

Goldman, D. and D.N. Lakdawalla

Read More >

HealthAffairs

Health Affairs Blog. 2016

Rapid Biomedical Innovation Calls For Similar Innovation In Pricing And Value Measurement

Goldman, D., S. Nussbaum, and M. Linthicum

Read More >

HealthAffairs

Health Affairs Blog. 2015

It’s Time For Value-Based Payment In Oncology

Goldman, D.P.D.N. Lakdawalla, and L. Newcomer

Read More >

HealthAffairs

Health Affairs Blog. 2012

Harnessing The Promise Of Comparative Effectiveness Research,

Goldman, D.P., et al.

Read More >

HealthAffairs

Health Affairs Blog. 2018

The Long Road To Value-Based Payment: The Case of Transcatheter Aortic Valve Replacement

Mattke, S., D.N. Lakdawalla, and D.P. Goldman

Read More >

Value in Health

Wall Street Journal. 2017

Take Me Out to the Pill Game

Goldman, D.P. and D. Lakdawalla

Read More >

Value in Health

Wall Street Journal. 2019

Health Care’s Killer App: Life Insurance

Goldman, D.P. and D. Lakdawalla

Read More >